Indian Pharma Market Grew 12.1% In August, AWACS Report

New Delhi : Indian pharmaceutical market (IPM) grew 12.1% in value and 4.8% in volumes, in the month of August on back of strong growth across all the therapy areas, according to market research firm AWACS.

IPM saw sales of Rs 16,239 crore during August.

The wholesale price index (WPI) inflation linked price hike allowed by the government has helped the pharma industry to increase by 10% on drugs under price control, along with monsoon linked infectious diseases.

The fastest growing categories are cardiac which grew at 13%, anti-infectives – 13% and gastrointestinal – 12%. Anti-diabetes and vitamins grew 9% respectively.

Augmentin of GSK, Glycomet of USV and Mixtard of Abbott, remain top-3 selling brands in India.

  • Related Posts

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Hyderabad: In a stern message to the pharmaceutical industry, Telangana Health Minister Damodar Rajanarsimha has ordered the Drug Control Authority (DCA) to take stringent action against companies and individuals involved…

    LOC issued against man who sold fake Ozempic worth Rs 180 crore to US firm

    New Delhi:  A lookout circular (LOC) has been issued against the man who allegedly sold fake Ozempic worth Rs 180 crore to a United States-based firm, officers have said. According…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Telangana HM orders action against misleading pharma ads, sale of substandard drugs

    Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet

    Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet

    AIIMS study finds catheter infections in hospital widespread across India

    AIIMS study finds catheter infections in hospital widespread across India

    MNCs seek restart of refurbished medical device imports

    MNCs seek restart of refurbished medical device imports